Last updated: July 15, 2024
Sponsor: Massachusetts General Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anxiety Disorders
Post-traumatic Stress Disorders
Panic Disorders
Treatment
Enhanced Standard Care
False Safety Behavioral Elimination Treatment (FSET)
Clinical Study ID
NCT06289621
2024P000420
K01TW012180
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participants diagnosed with a primary anxiety disorder (panic disorder, generalizedanxiety disorder, social anxiety disorder, or obsessive-compulsive disorder) orpost-traumatic stress disorder.
Exclusion
Exclusion Criteria:
- Participants who are acutely suicidal, have severe alcohol of substance usedisorder, or are engaged in another form of psychotherapy.
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Enhanced Standard Care
Phase:
Study Start date:
May 08, 2024
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
Stellenbosch University
Cape Town, 8005
South AfricaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.